These results are in agreement with the reports from the Katzav laboratory that showed that even wild-type VAV1 is sufficient to co-operate with mutant KRAS in generating PDAC [81] and NSCLC [83]. The gene discussed is VAV1; the disease is non-small cell lung carcinoma.